Previously, MXD3 overexpression was detected to elevate in glioblastoma [10], medulloblastoma [11], acute lymphoblastic leukemia cell proliferation [12], renal cell carcinoma [13], and hepatocellular carcinoma (HCC) [14]. This evidence concerns the gene MXD3 and hepatocellular carcinoma.